RIZATRIPTAN MSD 5 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

rizatriptan msd 5 mg tablets

merck sharp & dohme ireland (human health) limited - rizatriptan - tablet - 5 milligram(s) - selective serotonin (5ht1) agonists; rizatriptan

RIZATRIPTAN MSD 5 mg oral lyophilisates आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

rizatriptan msd 5 mg oral lyophilisates

merck sharp & dohme ireland (human health) limited - rizatriptan - oral lyophilisate - 5 milligram(s) - selective serotonin (5ht1) agonists; rizatriptan

RIZATRIPTAN MSD 10 mg Tablets आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

rizatriptan msd 10 mg tablets

merck sharp & dohme ireland (human health) limited - rizatriptan benzoate - tablet - 10 milligram(s) - selective serotonin (5ht1) agonists; rizatriptan

RIZATRIPTAN MSD 10 mg oral lyophilisates आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

rizatriptan msd 10 mg oral lyophilisates

merck sharp & dohme ireland (human health) limited - rizatriptan benzoate - oral lyophilisate - 10 milligram(s) - selective serotonin (5ht1) agonists; rizatriptan

HBvaxPRO vaccine न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

hbvaxpro vaccine

merck sharp & dohme (new zealand) limited - hepatitis b vaccine, rdna 10 µg/ml - suspension for injection - 10 mcg/ml - active: hepatitis b vaccine, rdna 10 µg/ml excipient: aluminium as amorphous aluminum hydroxyphosphate sulphate borax formaldehyde potassium thiocyanate sodium chloride water for injection - immunisation against infection caused by all known subtypes of hepatitis b virus. hbvaxpro should also prevent hepatitis d (caused by the delta virus) since hepatitis d does not occur in the absence of hepatitis b infection.

HBvaxPRO vaccine न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

hbvaxpro vaccine

merck sharp & dohme (new zealand) limited - hepatitis b vaccine, rdna 40 µg/ml - suspension for injection - 40 mcg/ml - active: hepatitis b vaccine, rdna 40 µg/ml excipient: aluminium as amorphous aluminum hydroxyphosphate sulphate borax formaldehyde potassium thiocyanate sodium chloride water for injection - immunisation against infection caused by all known subtypes of hepatitis b virus. hbvaxpro should also prevent hepatitis d (caused by the delta virus) since hepatitis d does not occur in the absence of hepatitis b infection.

MMR II Vaccine न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

mmr ii vaccine

merck sharp & dohme (new zealand) limited - measles vaccine 1000 tcid50 (at end of expiry); mumps vaccine 12500 tcid50 (at end of expiry); rubella vaccine 1000 tcid50 (at end of expiry) - suspension for injection - active: measles vaccine 1000 tcid50 (at end of expiry) mumps vaccine 12500 tcid50 (at end of expiry) rubella vaccine 1000 tcid50 (at end of expiry) excipient: dibasic potassium phosphate dibasic sodium phosphate monohydrate eagle minimum essential medium gelatin medium 199 monobasic potassium phosphate monobasic sodium phosphate monohydrate monosodium glutamate neomycin phenolsulfonphthalein sodium bicarbonate sorbitol sucrose water for injection - m-m-r ii is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.

Pneumovax 23 vaccine न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pneumovax 23 vaccine

merck sharp & dohme (new zealand) limited - pneumococcal polysaccharide vaccine 50 µg/ml (25mcg/dose of each of 23 named pneumococcal polysaccharides) - solution for injection - active: pneumococcal polysaccharide vaccine 50 µg/ml (25mcg/dose of each of 23 named pneumococcal polysaccharides) excipient: phenol sodium chloride water for injection - pneumovax 23 is indicated for vaccination against pneumococcal disease caused by those pneumococcal types included in the vaccine.